Tixagevimab/cilgavimabTixagevimab/cilgavimab, sold under the brand name Evusheld, is a combination of two human monoclonal antibodies, tixagevimab (AZD8895) and cilgavimab (AZD1061) targeted against the surface spike protein of SARS-CoV-2 used to prevent COVID-19. Read from the Drugbox of the Wikipedia article Tixagevimab/cilgavimab, revision 1341782822.

Property

Value

Formula

C13114H20252N3496O4116S94, 295756.68 g/mol

The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.